CAR-TCR Summit Series

New Agenda Announcement! The cell therapy industry is beginning to show great promise with innovation in armouring technologies to improve safety, increased investment and successful IPOs. With multiple approvals paving the way for TCRs in solid tumours and CAR-Ts for autoimmune indications, the field is poised to regain momentum. The 8th CAR-TCR Summit Europe (25th - 27th February), is back to provide the perfect place to showcase your services and cutting-edge technologies to a curated audience of cell therapy decision-makers and industry leaders. Learn more here- https://ter.li/q827e9

Thank you for connecting with us at the CAR-TCR Summit Series! https://okt.to/zpJRha The event was marked with great presentations from industry experts in the CGT space and it was indeed a pleasure to share our latest advancements in concept-to-cure solutions. In case you missed us, check out the exclusive interview with Matthew Hewitt as he addresses challenges around new technology and scaling manufacturing to address larger patient populations. #celltherapy #cdmo #cartcr #advancedtherapies

🤝🏼Thank you to everyone who stopped by our booth at CAR-TCR Summit Series in Boston! Missed us at the Summit? No worries! Join our technical webinar about uncovering hidden immune cell killing to understand anti-tumor activity. #CellTherapy #Immunotherapy

🧬 Thank you to everyone who stopped by Booth 45 at CAR-TCR Summit Series! 🧬 It was amazing connecting with so many innovators in the cell therapy space. Here are some key takeaways from the CellFE team: 🔑 Non-viral and automated technology is paving the way for safer, faster, and more efficient gene editing. 🔑 Unlocking resting T cells and streamlining CAR-T workflows is more critical than ever for scaling successful therapies. 🔑 Collaboration is key! We're excited about the partnerships and ideas shared at the event. Missed us at the summit? No worries! You can still schedule a meeting to learn how we can support your cell therapy manufacturing needs. Looking forward to staying connected and continuing the conversation! Schedule a meeting:https://lnkd.in/eUBZ2JRa Connect with our team: https://lnkd.in/eS7gGbwT #CellTherapy #innovation #geneediting #CARTCR #CART #RestingTCells #Biotech #NonViral #Partnerships

🌟 A look back at the CAR-TCR Summit in Boston! 🌟 Last week, our team had the pleasure of attending the CAR-TCR Summit Series in Boston, a must-attend event for cell and gene therapy professionals. It was a valuable opportunity to exchange ideas, discover the latest innovations and discuss the challenges and opportunities in our field. We would like to extend our warmest thanks to the organisers for their dedication in making this event a success. 🙏 Eleni Topollaj and @NitaM. Your commitment to bringing together experts and thought leaders is key to advancing research and development in CAR-T and TCR therapy. #CAR_T #TCR #CellTherapy #Innovation #CARTCR #GeneTherapy

Our Cell and Gene team had an amazing time at Hanson Wade Group’s CAR TCR Summit last week meeting so many inspiring professionals and sharing insights about the Cell and Gene industry. Your interest and conversations made this exhibition truly memorable. Whether you visited our booth, attended our sessions, or connected with us over a quick chat, we appreciate the time you took to engage with us. Looking forward to staying in touch and exploring opportunities to collaborate in the future! #CellandGene #CARTCR #CellTherapy #RealizingPotentialTogether

This month, the Immatics team traveled to Boston for the 9th Annual CAR-TCR Summit Series, where insightful discussions on progress in the field of cell therapy took center stage. Our team members, Mamta Kalra, Delfi Krishna and Ali Mohamed, PhD advanced the conversation and showcased Immatics’ innovative work through presentations and panel sessions. Key takeaways from CAR-TCR Summit 2024 include: 👉There is a strong focus on shortening manufacturing processes and QC release times for autologous cell therapy to maximize patient access on a global scale and reduce cost of goods and vein-to-vein time. 👉New off-the-shelf technological solutions are being developed to advance cell therapy manufacturing, including new equipment and automation options. 👉The application of cell therapy is expanding beyond oncology to include autoimmune diseases, with promising progress made in the in vivo engineering of T cells via viral and mRNA platforms. We are proud of the contributions our team made and look forward to continuing our journey of innovation in cell therapy, with the ultimate goal of improving the lives of cancer patients. #CAR_TCR2024 #CellTherapy #Innovation #SummitRecap #CARTCR #ScienceResearch #cancer #oncology

Last week's event with Ori Biotech was great and our friends at Fierce Pharma did a great article on the collaboration. Jason C. Foster and I did our best Step Brothers impression, doing the interview with Fierce together. Even as we are moving past last week's event as well as Hanson Wade Group's CAR-TCR Summit Series, everyone is likely thinking about the Alliance for Regenerative Medicine's Meeting on the Mesa in 2 weeks. Looking forward to seeing everyone. Thanks!

Last week’s 9th Annual CAR-TCR Summit Series 2024 in Boston was a remarkable success for the Johnson & Johnson Innovative Medicine teams! Don't miss Maren Gaudig's insightful article on how Johnson & Johnson is revolutionizing patient experiences and removing barriers to access. Dive in to learn more! https://lnkd.in/eKEfbCC9